Low penetrance breast cancer susceptibility loci are associated with specific breast tumor subtypes: findings from the Breast Cancer Association Consortium
Annegien Broeks, Thilo Dörk(Hannover Re (Germany)), Fleur Hammet(Monash Health), David D. Ørsted(University of Copenhagen), Marjanka K. Schmidt(University of Cambridge), Hiltrud Brauch(German Cancer Research Center), Frederik Marmé(Heidelberg University), Laura van ‘t Veer, Thomas Brüning(Institute for Prevention and Occupational Medicine), Fergus J. Couch(Mayo Clinic), Peter A. Fasching(Universitätsklinikum Erlangen), Jenny Chang‐Claude(Universität Hamburg), Beate Pesch(Institute for Prevention and Occupational Medicine), Roger L. Milne(The University of Melbourne), Arif B. Ekici(University Medical Center Groningen), Diljit Kaur‐Knudsen(University of Copenhagen), Arndt Hartmann(Universitätsklinikum Erlangen), Hans‐Peter Fischer(University of Bonn), Javier Benı́tez(Spanish National Cancer Research Centre), Henrik Flyger(University of Copenhagen), Primitiva Menéndez Rodríguez(Hospital Monte Naranco), Christina Justenhoven(Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology), José Ignacio Arias Pérez, Michael Bremer(Medizinische Hochschule Hannover), Sandrine Tchatchou(Mount Sinai Hospital), Ute Hamann(German Cancer Research Center), Renate H. M. de Groot(Indonesia Open University), Stig E. Bojesen(University of Copenhagen), Børge G. Nordestgaard(Gentofte Hospital), Letitia Smith(The University of Melbourne), Christof Sohn, Sebastian M. Jud, Alexander Hein, Andreas Schneeweiß(German Cancer Research Center), Melissa C. Southey(The University of Melbourne), Vincent T.H.B.M. Smit(Leiden University Medical Center), Gillian S. Dite(University of Melbourne), Pilar Zamora(Hospital Universitario La Paz), Shan Wang‐Gohrke(Universität Ulm), R. Schulz-Wendtland(Universitätsklinikum Erlangen), Barbara Burwinkel(German Cancer Research Center), Matthias W. Beckmann, John L. Hopper(The University of Melbourne), Mark E. Sherman(National Cancer Institute), Johann H. Karstens(Medizinische Hochschule Hannover), Yon‐Dschun Ko(Johanniter-Krankenhaus Bonn), Peter Hillemanns(Medizinische Hochschule Hannover), Carmel Apicella(The University of Melbourne), Hans‐Peter Sinn(Heidelberg University)
Cited by 173
Related Papers
A Gene-Expression Signature as a Predictor of Survival in Breast Cancer
|New England Journal of Medicine|2002|6.5k
Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis
|The Lancet|2014|4.7k
First M87 Event Horizon Telescope Results. I. The Shadow of the Supermassive Black Hole
|The Astrophysical Journal Letters|2019|4.2k
Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel
|European Heart Journal|2017|3.8k
Average Risks of Breast and Ovarian Cancer Associated with BRCA1 or BRCA2 Mutations Detected in Case Series Unselected for Family History: A Combined Analysis of 22 Studies
|The American Journal of Human Genetics|2003|3.7k